Pulmonary embolism (PE)

Diagnostic and therapeutic approach

  1. Diagnosis
  2. Scores
  3. Treatment
  4. Pharmaceuticals
  5. ESC recommandations

Pharmaceuticals

  1. Apixaban (Eliquis)
  2. Dabigatran (Pradaxa)
  3. Enoxaparin (Clexane)
  4. Fondaparinus (Arixtra)
  5. RtPA (Actilyse)
  6. Urokinase
  7. Rivaroxaban (Xarelto)
  8. Edoxaban (Lixiana)
  9. Anticoagulants

Anticoagulants

(Acenocoumarol=Sintrom et Phenprocoumone=Marcoumar).

Dosage

Variable from one individual to another. Aiming an INR of 2 to 3. TP between 25 and 35%.

Contra-indications

  • Known hypersensitivity to acenocoumarol or coumarin derivatives.
  • Pregnancy.
  • Lack of cooperation from the patient (eg unsupervised and senile patients, alcoholics and people with psychiatric disorders.).
  • Pathological states for which the danger of bleeding outweighs the anticipated clinical benefit.

http://www.drugs.com/international/acenocoumarol.html